With overall global identity fraud rate stabilizing, high-quality attacks increased by 180% over 2024-2025 Sumsub, a global leader in verification and fraud prevention, today released its Identity Fraud Report 2025-2026, analyzing millions of verification checks and 4,000,000+ fraud attempts between 2024-2025*. The study blends global and regional dynamics from internal data with findings from Sumsub's […]

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, and ophthalmologic diseases, announces thatthe supplementary application for the 9 mg dosage of mazdutide, an innovative glucagon (GCG)/ glucagon-like peptide-1 (GLP-1) dual receptor agonist, for the long-term weight management

Advances in AI have spawned a more mature, industrialized fraud ecosystem, as fraudsters shift from low-effort schemes to high-quality, AI-augmented attacks Sumsub, a global verification and anti-fraud leader, has released its fifth annual Identity Fraud Report 2025-2026, revealing a global “Sophistication Shift”-a new phase of digital fraud driven by AI and the professionalization of fraud-as-a-service

PONY AI Inc. Realized Gen-7 Robotaxi city-wide UE Breakeven; Set to Surpass 2025 Fleet Target and Expand to 3,000+ Vehicles by End of Next Year GlobeNewswire November 25, 2025 Successful dual primary listing in Hong Kong — Raised more than US$800 million1 to accelerate mass production, large-scale commercialization, R&D innovation and new market expansion. Official

NICE Recommends AUCATZYL(R) (obecabtagene autoleucel) as a Treatment Option for Adult Patients (greater-than or equal to26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1) AUCATZYL(R) will be available through routine commissioning by the UK National Health Service (NHS) GlobeNewswire November 25, 2025 LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics

Rebuilding Canada's Fisheries is Key to Ocean Recovery and Coastal Prosperity 2025 Fishery Audit shows one-third of depleted fish stocks have rebuilding plans; federal action still needed to protect oceans, the economy, and coastal communities GlobeNewswire November 25, 2025 OTTAWA, Ontario, traditional, unceded territory of the Algonquin Anishnaabeg People, Nov. 25, 2025 (GLOBE NEWSWIRE) —

Chargebee Selected by Future to Power Global Subscription Growth Leading global media platform selects Chargebee as enterprise subscription management partner to power unified digital transformation GlobeNewswire November 25, 2025 NORTH BETHESDA, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) — Chargebee, a leading billing and monetisation platform, today announced that Future, the global platform for specialist media,

Macomics Announces Updated Data of the ENIGMAC Drug Discovery Platform and The Role of Macrophages in Fibrotic Disease GlobeNewswire November 25, 2025 EDINBURGH, United Kingdom and CAMBRIDGE, United Kingdom, Nov. 25, 2025 (GLOBE NEWSWIRE) — Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC(TM) platform in macrophage mediated antifibrotic

Canadians Take on More Credit Amid Lower Interest Rates as Mortgage Churn Rises and Economic Disparities Deepen GlobeNewswire November 25, 2025 Key findings from TransUnion report: Total consumer debt rose to $2.6 trillion, driven by increased mortgage balances amid falling interest rates; mortgage originations jumped 18% YoY as Canadians opted for shorter-term fixed mortgages. Delinquency

Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 With Halborn Security Audit and 95% Allocation in Phase 6 GlobeNewswire November 25, 2025 DUBAI, United Arab Emirates, Nov. 25, 2025 (GLOBE NEWSWIRE) — A new shift is taking place in the market as investors search for the top crypto that still offers real upside. Many established